InvestorsHub Logo
Followers 1
Posts 260
Boards Moderated 0
Alias Born 09/11/2017

Re: HorizenBull post# 9058

Wednesday, 01/15/2020 11:45:29 AM

Wednesday, January 15, 2020 11:45:29 AM

Post# of 9941
I'm still not parked in the it's a scam camp, however what is apparent is that they're really struggling to mature their therapeutic pipeline as well as biosynthesis commercialization. They are slowly proving to be a team with great potential, but may never realize it as they seem to not be able to make the sausage. Pipeline candidates and their respective clinical dates have changed multiple times in the past 5 yrs. They've made late changes to formulations. Their novel ocular delivery system was supposed to be a game changer now there's concern they may be abandoning it. We've seen first hand how they tweak their presentation milestones to paint the picture that they are hitting their objectives when they really just keep missing the mark and kicking the can down the road.

They keep everyone on their toes in suspense with their secret partners. Secret CDMO partners, secret pharmaceutical partners, etc. I don't actually think they have any partners at all. They are going to miss another year of warrants, raise more cash via dilutive means and set the company back only further with additional commercialization delays to biosynthesis all while watching the share count double to get them the cash they'll need to get through '20 and beyond.

Adams, please orchestrate another great pump by May to head fake folks so that I can shave my position down significantly.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INM News